Angioplasty, inflammation, and antiplatelet agents
Endothelium-independent coronary microvascular function: All vessels are not created equally
Lessons from the implantable atrial defibrillator
Assessing quality and outcomes for percutaneous coronary intervention: Choosing statistical models, outcomes, time periods, and patient populations
Heart failure with preserved systolic function after myocardial infarction: A growing burden?
Coronary calcium: Is racial profiling necessary?
Left atrial thrombus, transient ischemic attack, and atrial fibrillation: Does left atrial thrombus predict? Does absence protect?
Anticoagulation in acute cardiac care in patients with chronic kidney disease
The Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) study: To what extent should the results be generalizable?
Design of the Genetics of Early Onset Cardiovascular Disease (GENECARD) study
Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease
Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: Are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study
Heterogeneity of microvascular dysfunction in women with chest pain not attributable to coronary artery disease: Implications for clinical practice
Effect of tenecteplase versus alteplase on platelets during the first 3 hours of treatment for acute myocardial infarction: The Assessment of the Safety and Efficacy of a New Thrombolytic Agent (ASSENT-2) platelet substudy
Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: Results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study
Smoking and health outcomes after percutaneous coronary intervention
Adjusting for patient differences in predicting hospital mortality for percutaneous coronary interventions in the Clinical Outcomes Assessment Program
Use patterns of low-molecular weight heparin and the impact on length of stay in patients hospitalized for atrial fibrillation
What characterizes episodes of atrial fibrillation requiring cardioversion? Experience from patients with an implantable atrial cardioverter
Left atrial thrombus predicts transient ischemic attack in patients with atrial fibrillation
Limitations of current risk-adjustment models in the era of coronary stenting
Cytokine response after percutaneous coronary intervention in stable angina: Effect of selective glycoprotein IIb/IIIa receptor antagonism
Elective versus provisional intra-aortic balloon pumping in high-risk percutaneous transluminal coronary angioplasty
Importance of time-to-reperfusion in patients with acute myocardial infarction with and without cardiogenic shock treated with primary percutaneous coronary intervention
Usefulness of the pediatric electrocardiogram in detecting left ventricular hypertrophy: Results from the Prospective Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P2C2 HIV) multicenter study
Coronary artery calcification in black women and white women
Interatrial septal mobility predicts larger shunts across patent foramen ovales: An analysis with transmitral Doppler scanning
Nickel release after implantation of the Amplatzer occluder
Heart failure after myocardial infarction: Prevalence of preserved left ventricular systolic function in the community
Comparison of a silicon carbide-coated stent versus a noncoated stent in human beings: The Tenax versus Nir Stent Study's long-term outcome
Measurements of serum cardiac troponin T in patients with heart failure
Measurements of serum cardiac troponin T in patients with heart failure
Tranilast for restenosis: Efficacious or not?
Tranilast for restenosis: Efficacious or not?
Tranilast for restenosis: Efficacious or not?